Glutathione IV in Kollam,
screened entry, off-label cosmetic, physician-supervised.

Glutathione IV is safe when administered under dermatologist supervision with proper safety screening. DermaVue requires baseline liver function tests before treatment and monitors liver function every 4 to 6 sessions. Published studies have documented liver function abnormalities in unsupervised settings, which is why medical oversight is essential.

Most patients observe gradual improvement in skin tone evenness after 4 to 6 sessions. A typical course involves 6 to 8 weekly sessions followed by monthly maintenance. Individual response varies based on baseline pigmentation, sun exposure in Kollam's coastal environment and whether you are using complementary treatments such as chemical peels and topicals.

Three fundamental differences. First, every infusion at DermaVue Kollam is administered under MD DVL dermatologist supervision — not by beauty staff. Second, pre-treatment liver function tests and complete blood count are mandatory before the first session, with repeat LFTs every 4 to 6 sessions. Third, Glutathione IV is integrated within a comprehensive plan with chemical peels, Q-switched laser toning and medical-grade topicals so the tone evenness holds longer than IV alone. Pharmaceutical-grade L-glutathione is used from verified sources with cold-chain maintenance.

Glutathione-related improvement requires ongoing maintenance. Pigmentation is a dynamic process influenced by UV exposure, hormones and aging. Without maintenance sessions and consistent sun protection, gradual return to baseline is expected, particularly in Kollam's high-UV coastal environment. This is true for all pigmentation treatments, not just glutathione.

When administered under medical supervision with safety screening, common side effects are mild, including temporary tenderness at the IV site and occasional mild nausea. Published research has documented liver function abnormalities in some IV-treated patients, which is why DermaVue conducts pre-treatment and periodic liver function monitoring.

Glutathione is not specifically FDA-approved as a skin lightening agent. It is recognised as a dietary supplement and antioxidant. At DermaVue, glutathione IV is administered as part of dermatologist-directed aesthetic care under appropriate medical supervision, not as an FDA-approved skin lightening drug.

DermaVue requires baseline liver function tests and complete blood count before the first session. Liver function is rechecked every 4 to 6 sessions. Any abnormality triggers immediate reassessment and possible treatment modification. This protocol distinguishes clinical IV therapy from unmonitored salon drips in Kollam.

Glutathione addresses melanin overproduction through tyrosinase inhibition, which can benefit melasma and sun damage. However, for melasma specifically, the strongest clinical evidence supports chemical peels, laser toning, topical depigmenting agents and oral tranexamic acid. Our dermatologists typically use glutathione as a complementary treatment rather than a standalone solution for melasma.

Patients with liver disease, abnormal liver function, known glutathione allergy, or those who are pregnant or breastfeeding should not receive IV glutathione. Patients currently on hepatotoxic medications require careful evaluation. These contraindications are assessed during the pre-treatment screening at DermaVue Kollam.

Glutathione IV is paired with chemical peels (glycolic or TCA), low-fluence Q-switched Nd:YAG laser toning, medical-grade topical regimens (vitamin C, niacinamide, tretinoin) and tranexamic acid where indicated. The combined plan typically delivers more even tone results than IV alone, with the IV adding antioxidant support and the peels plus laser working directly on pigment.